Clinical Trials Directory

Trials / Completed

CompletedNCT03387644

Pregabalin Premedication for Conscious Sedation

Pregabalin Premedication for Conscious Sedation for Flexible Bronchoscopy: A Randomized Double Blind Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Conscious sedation is usually required during flexible bronchoscopy. Sedation should be done without causing respiratory depression or loss of consciousness. The present study was designed to evaluate the advantage of pregabalin pre-medication on reducing sedatives and respiratory depression for patients undergoing flexible bronchoscopy with dexmedetomidine and midazolam.

Detailed description

Seventy patients undergoing elective flexible bronchoscopy were randomly divided into two equal groups, 35 patients each. All patients received premedication one hour before the procedure. PG group received 150 mg pregabalin and C group received placebo. All patients sedated to achieve optimum working conditions. Intra-operative respiratory rate and post procedure patients' and pulmonologists' satisfaction were compared in both groups.

Conditions

Interventions

TypeNameDescription
DRUGPregabalin (PG)Pregabalin 150 mg one hour before the procedure as premedication.
DRUGControl placebo (C)Placebo tablets one hour before the procedure as premedication.

Timeline

Start date
2015-04-15
Primary completion
2016-11-24
Completion
2017-05-16
First posted
2018-01-02
Last updated
2018-01-02

Source: ClinicalTrials.gov record NCT03387644. Inclusion in this directory is not an endorsement.